Toxicoproteomics: proteomics applied to toxicology and pathology.

Global measurement of proteins and their many attributes in tissues and biofluids defines the field of proteomics. Toxicoproteomics, as part of the larger field of toxicogenomics, seeks to identify critical proteins and pathways in biological systems that are affected by and respond to adverse chemical and environmental exposures using global protein expression technologies. Toxicoproteomics integrates 3 disciplinary areas: traditional toxicology and pathology, differential protein and gene expression analysis, and systems biology. Key topics to be reviewed are the evolution of proteomics, proteomic technology platforms and their capabilities with exemplary studies from biology and medicine, a review of over 50 recent studies applying proteomic analysis to toxicological research, and the recent development of databases designed to integrate -Omics technologies with toxicology and pathology. Proteomics is examined for its potential in discovery of new biomarkers and toxicity signatures, in mapping serum, plasma, and other biofluid proteomes, and in parallel proteomic and transcriptomic studies. The new field of toxicoproteomics is uniquely positioned toward an expanded understanding of protein expression during toxicity and environmental disease for the advancement of public health.

[1]  John R Yates,et al.  Nuclear Membrane Proteins with Potential Disease Links Found by Subtractive Proteomics , 2003, Science.

[2]  Visith Thongboonkerd,et al.  Proteomic identification of nitrated proteins in Alzheimer's disease brain , 2003, Journal of neurochemistry.

[3]  E. Lock,et al.  A correlation between a proteomic evaluation and conventional measurements in the assessment of renal proximal tubular toxicity. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  K. Malcolm,et al.  A Genomic and Proteomic Analysis of Activation of the Human Neutrophil by Lipopolysaccharide and Its Mediation by p38 Mitogen-activated Protein Kinase* , 2002, The Journal of Biological Chemistry.

[5]  Ruedi Aebersold,et al.  The Application of New Software Tools to Quantitative Protein Profiling Via Isotope-coded Affinity Tag (ICAT) and Tandem Mass Spectrometry , 2003, Molecular & Cellular Proteomics.

[6]  R. Dwek,et al.  Towards complete analysis of the platelet proteome , 2002, Proteomics.

[7]  X. Xiao,et al.  Development of Proteomic Patterns for Detecting Lung Cancer , 2004, Disease markers.

[8]  S. Cordwell,et al.  Subproteomics based upon protein cellular location and relative solubilities in conjunction with composite two‐dimensional electrophoresis gels , 2000, Electrophoresis.

[9]  S. Takeda,et al.  Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin. , 2003, The American journal of pathology.

[10]  E. Petricoin,et al.  SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. , 2004, Current opinion in biotechnology.

[11]  S. De Flora,et al.  Proteomic analysis as related to transcriptome data in the lung of chromium(VI)-treated rats. , 2004, International journal of oncology.

[12]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[13]  L. Lomas,et al.  Application of surface‐enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbumin‐α: A biomarker of compound‐induced skeletal muscle toxicity in the rat , 2002, Electrophoresis.

[14]  David Wield,et al.  Cutting-edge technology , 1990 .

[15]  S. Seki,et al.  Proteome analysis of rat hepatic stellate cells , 2000, Hepatology.

[16]  T. Yip,et al.  Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. , 2003, Clinical chemistry.

[17]  T. Haystead,et al.  A functional proteomics approach to signal transduction. , 2003, Recent progress in hormone research.

[18]  G. Page,et al.  Oxidative modification of hepatic mitochondria protein thiols: effect of chronic alcohol consumption. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[19]  Richard D. Smith,et al.  Phosphoprotein isotope-coded solid-phase tag approach for enrichment and quantitative analysis of phosphopeptides from complex mixtures. , 2003, Analytical chemistry.

[20]  John R. Yates,et al.  CEBS object model for systems biology data, SysBio-OM , 2004, Bioinform..

[21]  L. Crosby,et al.  Toxicogenomics, Drug Discovery, and the Pathologist , 2002, Toxicologic pathology.

[22]  B. Weigl,et al.  Lab-on-a-chip for drug development. , 2003, Advanced drug delivery reviews.

[23]  F. Witzmann,et al.  Proteomic analysis of simulated occupational jet fuel exposure in the lung , 1999, Electrophoresis.

[24]  J. Hoheisel,et al.  Antibody microarrays: promises and problems. , 2002, BioTechniques.

[25]  Alan Herbert,et al.  The four Rs of RNA-directed evolution , 2003, Nature Genetics.

[26]  Rui Vitorino,et al.  Identification of human whole saliva protein components using proteomics , 2004, Proteomics.

[27]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[28]  L. Babiss,et al.  Toxicogenomics in predictive toxicology in drug development. , 2004, Chemistry & biology.

[29]  Thomas P Conrads,et al.  SELDI-TOF MS for diagnostic proteomics. , 2003, Analytical chemistry.

[30]  B. Olsson,et al.  Protein expression signatures identified in Mytilus edulis exposed to PCBs, copper and salinity stress. , 2000, Marine environmental research.

[31]  S. Pelech.  Tracking cell signaling protein expression and phosphorylation by innovative proteomic solutions. , 2004, Current pharmaceutical biotechnology.

[32]  F. Witzmann,et al.  Proteomic analysis of the renal effects of simulated occupational jet fuel exposure , 2000, Electrophoresis.

[33]  L. Pohl,et al.  Immunohistochemical detection of protein adducts of 2,4-dinitrochlorobenzene in antigen presenting cells and lymphocytes after oral administration to mice: lack of a role of Kupffer cells in oral tolerance. , 2001, Chemical research in toxicology.

[34]  M. Kinter,et al.  Proteomic Analysis of Oxidative Stress-resistant Cells , 2004, Molecular & Cellular Proteomics.

[35]  A. LeBlanc,et al.  Estrogen and Androgen Protection of Human Neurons against Intracellular Amyloid β1-42 Toxicity through Heat Shock Protein 70 , 2004, The Journal of Neuroscience.

[36]  K. Tomer,et al.  Effects of TCDD upon IκB and IKK subunits localized in microsomes by proteomics , 2002 .

[37]  R. Ulrich,et al.  Molecular profiling approaches for identifying novel biomarkers. , 2004, Expert opinion on drug safety.

[38]  M. Iadarola,et al.  Cystatin C as a cerebrospinal fluid biomarker for pain in humans , 2003, Pain.

[39]  C. Borrebaeck,et al.  Single framework recombinant antibody fragments designed for protein chip applications. , 2002, BioTechniques.

[40]  J. Yates,et al.  Direct analysis of protein complexes using mass spectrometry , 1999, Nature Biotechnology.

[41]  Å. Wheelock,et al.  Isolation of rodent airway epithelial cell proteins facilitates in vivo proteomics studies of lung toxicity. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[42]  Michael M. Shi,et al.  Technologies for Individual Genotyping , 2002 .

[43]  Cathy H. Wu,et al.  UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..

[44]  J. A. Carroll,et al.  Mass spectrometry compatibility of two‐dimensional gel protein stains , 2001, Electrophoresis.

[45]  P. O’Farrell.  High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.

[46]  D. Eisenberg,et al.  Describing Biological Protein Interactions in Terms of Protein States and State Transitions , 2002, Molecular & Cellular Proteomics.

[47]  J. Stulík,et al.  Identification of new celiac disease autoantigens using proteomic analysis , 2003, Proteomics.

[48]  K. Khoo,et al.  Strategic shotgun proteomics approach for efficient construction of an expression map of targeted protein families in hepatoma cell lines , 2003, Proteomics.

[49]  T. Zhukov,et al.  Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. , 2003, Lung cancer.

[50]  Steffen Loft,et al.  Linking exposure to environmental pollutants with biological effects. , 2003, Mutation research.

[51]  J. Remacle,et al.  Stress-induced premature senescence as alternativetoxicological method for testing the long-term effectsof molecules under development in the industry , 2004, Biogerontology.

[52]  S. Shabalina,et al.  The mammalian transcriptome and the function of non-coding DNA sequences , 2004, Genome Biology.

[53]  Kaj Blennow,et al.  Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. , 2003, Brain research. Molecular brain research.

[54]  Patrick Camilleri,et al.  Protein expression analysis of drug‐mediated hepatotoxicity in the Sprague‐Dawley rat , 2002, Proteomics.

[55]  Emanuel F Petricoin,et al.  Serum proteomics in cancer diagnosis and management. , 2004, Annual review of medicine.

[56]  R. Tennant,et al.  Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. , 2002 .

[57]  John R Yates,et al.  Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology. , 2003, Analytical chemistry.

[58]  M. Mann,et al.  Analysis of proteins and proteomes by mass spectrometry. , 2001, Annual review of biochemistry.

[59]  M. Shi.  Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes. , 2002, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[60]  Andrea Crisanti,et al.  Protein arrays for serodiagnosis of disease. , 2004, Methods in molecular biology.

[61]  Robert P Tonge,et al.  Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[62]  D. Hochstrasser,et al.  A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease , 2003, Proteomics.

[63]  S. Wen,et al.  Rapid detection of the known SNPs of CYP2C9 using oligonucleotide microarray. , 2003, World journal of gastroenterology.

[64]  Yoshiya Oda,et al.  Quantitative chemical proteomics for identifying candidate drug targets. , 2003, Analytical chemistry.

[65]  M. Toledano,et al.  A Proteome Analysis of the Cadmium Response in Saccharomyces cerevisiae * , 2001, The Journal of Biological Chemistry.

[66]  K. Lillemoe,et al.  Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. , 2002, Cancer research.

[67]  M J Dunn,et al.  Zooming‐in on the proteome: Very narrow‐range immobilised pH gradients reveal more protein species and isoforms , 2001, Electrophoresis.

[68]  S. Kennedy.  The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[69]  Valentina Gianotti,et al.  A new integrated statistical approach to the diagnostic use of two‐dimensional maps , 2003, Electrophoresis.

[70]  Y. Av‐Gay,et al.  Kinome Analysis of Host Response to Mycobacterial Infection: a Novel Technique in Proteomics , 2003, Infection and Immunity.

[71]  J. Yates,et al.  An automated multidimensional protein identification technology for shotgun proteomics. , 2001, Analytical chemistry.

[72]  S. Komatsu,et al.  Proteomic analysis of brown planthopper: application to the study of carbamate toxicity. , 2004, Insect biochemistry and molecular biology.

[73]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[74]  Rolf Apweiler,et al.  Advances in the development of common interchange standards for proteomic data , 2004, Proteomics.

[75]  W. Cosand,et al.  Proteomics in the post-genome age. , 2001, Biopolymers.

[76]  M. Gerstein,et al.  A question of size: the eukaryotic proteome and the problems in defining it. , 2002, Nucleic acids research.

[77]  E. Pennisi.  A Low Number Wins the GeneSweep Pool , 2003, Science.

[78]  Daniel W Chan,et al.  Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population. , 2004, The Journal of urology.

[79]  B. Cravatt,et al.  Profiling serine hydrolase activities in complex proteomes. , 2001, Biochemistry.

[80]  A. Scaloni,et al.  Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell line specifically binding to aptameric cytotoxic GT oligomers. , 2003, European journal of biochemistry.

[81]  O. Ohara,et al.  A comprehensive approach for establishment of the platform to analyze functions of KIAA proteins: Generation and evaluation of anti‐mKIAA antibodies , 2004, Proteomics.

[82]  G. Opiteck,et al.  Identification of in vitro protein biomarkers of idiosyncratic liver toxicity. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[83]  K. Tomer,et al.  Toxicoproteomics: a parallel approach to identifying biomarkers. , 2003 .

[84]  P. Cutler,et al.  An integrated proteomic approach to studying glomerular nephrotoxicity , 1999 .

[85]  J. Klose.  Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues , 1975, Humangenetik.

[86]  D. Thompson,et al.  Application of proteomic technologies in the drug development process. , 2003, Toxicology letters.

[87]  Ben van Ommen,et al.  Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach. , 2003, Biochemical pharmacology.

[88]  Alexander Scherl,et al.  Nonredundant mass spectrometry: A strategy to integrate mass spectrometry acquisition and analysis , 2004, Proteomics.

[89]  Ruo-Pan Huang,et al.  Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. , 2002, Cancer research.

[90]  Ruo-Pan Huang.  Protein arrays, an excellent tool in biomedical research. , 2003, Frontiers in bioscience : a journal and virtual library.

[91]  Trisha N Davis,et al.  Protein localization in proteomics. , 2004, Current opinion in chemical biology.

[92]  Ruedi Aebersold,et al.  The study of macromolecular complexes by quantitative proteomics , 2003, Nature Genetics.

[93]  Jinghua Jin,et al.  Proteomic analysis of cellular responses to low concentration N‐methyl‐N′‐nitro‐N‐nitrosoguanidine in human amnion FL cells , 2003, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences.

[94]  Emanuel Petricoin,et al.  Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray , 2004, Laboratory Investigation.

[95]  U. Völker,et al.  Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds. , 2001, Toxicology.

[96]  Rolf Apweiler,et al.  Common interchange standards for proteomics data: Public availability of tools and schema. Report on the Proteomic Standards Initiative Workshop, 2nd Annual HUPO Congress, Montreal, Canada, 8–11th October 2003 , 2004, Proteomics.

[97]  Yan Li,et al.  Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy , 2004, Nature.

[98]  The Human Proteome Organization (HUPO) and Environmental Health , 2003, EHP toxicogenomics : journal of the National Institute of Environmental Health Sciences.

[99]  R. Wait,et al.  Fluorescence two‐dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli , 2002, Proteomics.

[100]  Fang Wang,et al.  The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two‐dimensional electrophoresis gels and identification of 325 distinct proteins , 2003, Proteomics.

[101]  N. Anderson,et al.  Cholesterol biosynthesis regulation and protein changes in rat liver following treatment with fluvastatin. , 2001, Toxicology letters.

[102]  Matthew Davison,et al.  Validation and development of fluorescence two‐dimensional differential gel electrophoresis proteomics technology , 2001, Proteomics.

[103]  N. Kaplowitz,et al.  Immune-mediated drug-induced liver disease. , 2002, Clinics in liver disease.

[104]  Dermot F. Reilly,et al.  Integration of Proteomics and Genomics in Platelets , 2004, Molecular & Cellular Proteomics.

[105]  Shigehiko Kanaya,et al.  Informatics for unveiling hidden genome signatures. , 2003, Genome research.

[106]  S. Ong,et al.  An evaluation of the use of two-dimensional gel electrophoresis in proteomics. , 2001, Biomolecular engineering.

[107]  H. Leffers,et al.  Two dimensional gel human protein databases offer a systematic approach to the study of cell proliferation and differentiation. , 1989, The International journal of developmental biology.

[108]  C. Sander,et al.  The HUPO PSI's Molecular Interaction format—a community standard for the representation of protein interaction data , 2004, Nature Biotechnology.

[109]  S. Patterson.  Proteomics: evolution of the technology. , 2003, BioTechniques.

[110]  R. Hargreaves,et al.  Clinical biomarkers in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[111]  J. Trent,et al.  Microarrays and toxicology: The advent of toxicogenomics , 1999, Molecular carcinogenesis.

[112]  Kelvin H. Lee,et al.  Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease , 2002, Electrophoresis.

[113]  George L. Wright,et al.  SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. , 2002, Expert review of molecular diagnostics.

[114]  T. Veenstra,et al.  Characterization of the Low Molecular Weight Human Serum Proteome*S , 2003, Molecular & Cellular Proteomics.

[115]  J. Yates,et al.  Organellar proteomics reveals Golgi arginine dimethylation. , 2004, Molecular biology of the cell.

[116]  G. Agrawal,et al.  Proteome analysis of differentially displayed proteins as a tool for investigating ozone stress in rice (Oryza sativa L.) seedlings , 2002, Proteomics.

[117]  The International HapMap Consortium,et al.  A physical map of the human genome , 2001 .

[118]  Chan‐Wha Kim,et al.  Analysis of proteins expressed in rat plasma exposed to dioxin using 2‐dimensional gel electrophoresis , 2003, Proteomics.

[119]  E. Lock,et al.  A potential biomarker of kidney damage identified by proteomics: preliminary findings , 2003, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[120]  E. Petricoin,et al.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.

[121]  P. Lord,et al.  Proteomic analysis of rat kidney cortex following treatment with gentamicin. , 2002, Journal of proteome research.

[122]  S. Cristoni,et al.  Development of new methodologies for the mass spectrometry study of bioorganic macromolecules. , 2003, Mass spectrometry reviews.

[123]  E. Winzeler,et al.  Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[124]  G. Lubec,et al.  Changes in the brain protein levels following administration of kainic acid , 2001, Electrophoresis.

[125]  Stephen W Michnick,et al.  Proteomics in living cells. , 2004, Drug discovery today.

[126]  K. A. Resing,et al.  Analysis of Signaling Pathways Using Functional Proteomics , 2002, Annals of the New York Academy of Sciences.

[127]  D. Geschwind,et al.  DNA microarrays: translation of the genome from laboratory to clinic , 2003, The Lancet Neurology.

[128]  D. Nerland,et al.  Selective covalent binding of acrylonitrile to Cys 186 in rat liver carbonic anhydrase III in vivo. , 2003, Chemical research in toxicology.

[129]  Davide Ricci,et al.  Atomic force microscopy : biomedical methods and applications , 2004 .

[130]  Rembert Pieper,et al.  Characterization of the human urinary proteome: A method for high‐resolution display of urinary proteins on two‐dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots , 2004, Proteomics.

[131]  Ela Hunt,et al.  An object model and database for functional genomics , 2004, Bioinform..

[132]  G. Scheele.  Two-Dimensional Gel Analysis of Soluble Proteins , 1975 .

[133]  Jonathan S. Reichner,et al.  Antibodies Immobilized as Arrays to Profile Protein Post-translational Modifications in Mammalian Cells* , 2004, Molecular & Cellular Proteomics.

[134]  Zeljko Bajzer,et al.  Novel map descriptors for characterization of toxic effects in proteomics maps. , 2003, Journal of molecular graphics & modelling.

[135]  Michael D Waters,et al.  Toxicogenomic approach for assessing toxicant-related disease. , 2003, Mutation research.

[136]  Richard D. Smith,et al.  Phosphoprotein isotope-coded affinity tag approach for isolating and quantitating phosphopeptides in proteome-wide analyses. , 2001, Analytical chemistry.

[137]  K. Lindpaintner,et al.  Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia , 2003, Amino Acids.

[138]  P. Ping.  Identification of novel signaling complexes by functional proteomics. , 2003, Circulation research.

[139]  N. Takahashi,et al.  Proteomics: advanced technology for the analysis of cellular function. , 2003, The Journal of nutrition.

[140]  Ben van Ommen,et al.  Nutrigenomics: exploiting systems biology in the nutrition and health arena. , 2002, Current opinion in biotechnology.

[141]  T. Veenstra,et al.  Serum protein fingerprinting. , 2003, Current opinion in molecular therapeutics.

[142]  G. Cohen,et al.  Death receptors leave a caspase footprint that Smacs of XIAP , 2003, Cell Death and Differentiation.

[143]  R. Bischoff,et al.  Methodological advances in the discovery of protein and peptide disease markers. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[144]  Bradley P. Coe,et al.  A tiling resolution DNA microarray with complete coverage of the human genome , 2004, Nature Genetics.

[145]  M Waters,et al.  Systems Toxicology and the Chemical Effects in Biological Systems (CEBS) Knowledge Base , 2003, EHP toxicogenomics : journal of the National Institute of Environmental Health Sciences.

[146]  J. Yates.  Mass spectral analysis in proteomics. , 2004, Annual review of biophysics and biomolecular structure.

[147]  B. Coyle,et al.  Early Drug Safety Evaluation: Biomarkers, Signatures, and Fingerprints , 2003, Drug metabolism reviews.

[148]  Frank A Witzmann,et al.  JP-8 jet fuel exposure alters protein expression in the lung. , 2003, Toxicology.

[149]  S Kennedy,et al.  Proteomic profiling from human samples: the body fluid alternative. , 2001, Toxicology letters.

[150]  T. Ideker,et al.  A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.

[151]  Alfred Bach,et al.  Transcriptomics in predictive toxicology. , 2002, Current opinion in drug discovery & development.

[152]  Sven Bergmann,et al.  Iterative signature algorithm for the analysis of large-scale gene expression data. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.

[153]  E. Petricoin,et al.  High-resolution serum proteomic features for ovarian cancer detection. , 2004, Endocrine-related cancer.

[154]  Loïc Dayon,et al.  Microfluidic systems in proteomics , 2003, Electrophoresis.

[155]  D. Hochstrasser,et al.  Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. , 1996, Biotechnology & genetic engineering reviews.

[156]  D. Grainger,et al.  Toward immobilized antibody microarray optimization: print buffer and storage condition comparisons on performance. , 2004, Biomedical sciences instrumentation.

[157]  M. Arcellana‐Panlilio,et al.  Cutting-edge technology. I. Global gene expression profiling using DNA microarrays. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[158]  S. Kingsmore,et al.  Multiplexed protein profiling on microarrays by rolling-circle amplification , 2002, Nature Biotechnology.

[159]  W. Hiddemann,et al.  Correlation of protein expression and gene expression in acute leukemia , 2003, Cytometry. Part B, Clinical cytometry.

[160]  F. Staedtler,et al.  Toxicogenomics in Drug Development , 2003, Toxicologic pathology.

[161]  M. Mann,et al.  Directed Proteomic Analysis of the Human Nucleolus , 2002, Current Biology.

[162]  Frank A Witzmann,et al.  Cutting-edge technology. II. Proteomics: core technologies and applications in physiology. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[163]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[164]  J. Uetrecht,et al.  Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system. , 2002, Current drug metabolism.

[165]  L. Hood,et al.  Complementary Profiling of Gene Expression at the Transcriptome and Proteome Levels in Saccharomyces cerevisiae*S , 2002, Molecular & Cellular Proteomics.

[166]  G. Schoenhals,et al.  The human plasma proteome: A biomarker pool too deep to explore? , 2006 .

[167]  F. Witzmann,et al.  Analysis of rat testicular protein expression following 91‐day exposure to JP‐8 jet fuel vapor , 2003, Proteomics.

[168]  K. Harada,et al.  Proteomics approach on microcystin binding proteins in mouse liver for investigation of microcystin toxicity. , 2004, Toxicon : official journal of the International Society on Toxinology.

[169]  P. Cash,et al.  Protein characterization by two-dimensional gel electrophoresis. , 2003, Methods in molecular medicine.

[170]  A. Vlahou,et al.  A novel approach toward development of a rapid blood test for breast cancer. , 2003, Clinical breast cancer.

[171]  G. Scheele,et al.  Two-dimensional gel analysis of soluble proteins. Charaterization of guinea pig exocrine pancreatic proteins. , 1975, The Journal of biological chemistry.

[172]  R. Aebersold,et al.  Analysis, statistical validation and dissemination of large-scale proteomics datasets generated by tandem MS. , 2004, Drug discovery today.

[173]  A. B. Maunsbach,et al.  Biomedical Electron Microscopy: Illustrated Methods and Interpretations , 1998 .

[174]  D. Haussler,et al.  A physical map of the human genome , 2001, Nature.

[175]  D. Ornstein,et al.  Proteomics to diagnose human tumors and provide prognostic information. , 2004, Oncology.

[176]  Weida Tong,et al.  ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. , 2003, Environmental health perspectives.

[177]  K. Resing,et al.  Toward the phosphoproteome , 2001, Nature Biotechnology.

[178]  Marjan S. Bolouri,et al.  Integrated Analysis of Protein Composition, Tissue Diversity, and Gene Regulation in Mouse Mitochondria , 2003, Cell.

[179]  W. Krol,et al.  Comparison of the hemoglobin adducts formed by administration of N-methylolacrylamide and acrylamide to rats. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[180]  E. Holland,et al.  Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. , 2004, Analytical chemistry.

[181]  Ronald J. Moore,et al.  Toward a Human Blood Serum Proteome , 2002, Molecular & Cellular Proteomics.

[182]  Nan Hu,et al.  2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers* , 2002, Molecular & Cellular Proteomics.

[183]  R. Scopes,et al.  Analysis of Proteins , 1998 .

[184]  Richard D. Smith,et al.  Phosphoprotein isotope-coded affinity tags: application to the enrichment and identification of low-abundance phosphoproteins. , 2002, Analytical chemistry.

[185]  E. Diamandis.  Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool , 2004, Molecular & Cellular Proteomics.

[186]  A. Bernard,et al.  Susceptibility to oxidative stress: proteomic analysis of bronchoalveolar lavage from ozone‐sensitive and ozone‐resistant strains of mice , 2003, Proteomics.

[187]  N. Anderson,et al.  Multi‐component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteome , 2003, Proteomics.

[188]  D. Benndorf,et al.  Use of proteomics and physiological characteristics to elucidate ecotoxic effects of methyl tert‐butyl ether in Pseudomonas putida KT2440 , 2003, Proteomics.

[189]  R L Carpenter,et al.  Toxicity of chemical mixtures:Proteomic analysis of persisting liver and kidney protein alterations induced by repeated exposure of rats to JP‐8 jet fuel vapor , 2000, Electrophoresis.

[190]  J. Eriksson,et al.  Identification of ATP-synthase as a novel intracellular target for microcystin-LR. , 2003, Chemico-biological interactions.

[191]  John R Yates,et al.  A Plasmodium gene family encoding Maurer's cleft membrane proteins: structural properties and expression profiling. , 2004, Genome research.

[192]  S. Douc-Rasy,et al.  TP53 family members and human cancers , 2003, Human mutation.

[193]  D. Amacher,et al.  A toxicologist's guide to biomarkers of hepatic response , 2002, Human & experimental toxicology.

[194]  M. Greeley,et al.  Proteomics in Zebrafish Exposed to Endocrine Disrupting Chemicals , 2003, Ecotoxicology.

[195]  Jérôme Euzenat,et al.  Grasping at molecular interactions and genetic networks in Drosophila melanogaster using FlyNets, an Internet database , 1999, Nucleic Acids Res..

[196]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[197]  E. Tribulato,et al.  Identification of in vivo and in vitro lemon mutants by RAPD markers , 1995 .

[198]  M. Ferrari,et al.  Clinical proteomics: Written in blood , 2003, Nature.

[199]  Pierre Hainaut,et al.  p53 protein variants: structural and functional similarities with p63 and p73 isoforms , 2004, Oncogene.

[200]  G. Anderson,et al.  Nanoscale proteomics , 2004, Analytical and bioanalytical chemistry.

[201]  C. Hogstrand,et al.  Application of genomics and proteomics for study of the integrated response to zinc exposure in a non-model fish species, the rainbow trout. , 2002, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[202]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[203]  C. Southan.  Has the yo‐yo stopped? An assessment of human protein‐coding gene number , 2004, Proteomics.

[204]  Dennis W Wilson,et al.  Protein targets of 1,4‐benzoquinone and 1,4‐naphthoquinone in human bronchial epithelial cells , 2003, Proteomics.

[205]  Sergio Contrino,et al.  ArrayExpress—a public repository for microarray gene expression data at the EBI , 2004, Nucleic Acids Res..

[206]  R. Tonge,et al.  Quantitative proteomic analysis of mouse liver response to the peroxisome proliferator diethylhexylphthalate (DEHP) , 2001, Archives of Toxicology.

[207]  Frank D Sistare,et al.  Serum Troponins as Biomarkers of Drug-Induced Cardiac Toxicity , 2004, Toxicologic pathology.

[208]  Robert J Chalkley,et al.  Mass Spectrometric Analysis of Protein Mixtures at Low Levels Using Cleavable 13C-Isotope-coded Affinity Tag and Multidimensional Chromatography* , 2003, Molecular & Cellular Proteomics.

[209]  S. Mandel,et al.  cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[210]  H. Goodman,et al.  Characterization of the Low-Molecular-Weight RNAs Associated with the 70S RNA of Rous Sarcoma Virus , 1973, Journal of virology.

[211]  D. Driesch,et al.  Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip technology. , 2004, International journal of oncology.

[212]  John I. Clark,et al.  Shotgun identification of protein modifications from protein complexes and lens tissue , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[213]  M. Rivera,et al.  Analysis of genomic and proteomic data using advanced literature mining. , 2003, Journal of proteome research.

[214]  P. Cole,et al.  Kinase chips hit the proteomics era. , 2001, Trends in biochemical sciences.

[215]  P Berndt,et al.  Two‐dimensional database of mouse liver proteins. An update , 2001, Electrophoresis.

[216]  D. Baunsgaard,et al.  Mechanisms of hydrazine toxicity in rat liver investigated by proteomics and multivariate data analysis , 2004, Proteomics.

[217]  R. Mortishire-Smith,et al.  A proteomic investigation of drug-induced steatosis in rat liver. , 2004, Chemical research in toxicology.

[218]  K. Tomer,et al.  Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. , 2003, Carcinogenesis.

[219]  D. Liebler,et al.  Sequence Mapping of Epoxide Adducts in Human Hemoglobin with LC−Tandem MS and the Salsa Algorithm , 2002 .

[220]  A. Görg,et al.  Analytical IPG-Dalt. , 1999, Methods in molecular biology.

[221]  D. Chan,et al.  Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry , 2004, Clinical Cancer Research.

[222]  Y. Oh,et al.  Proteomic analysis reveals upregulation of calreticulin in murine dopaminergic neuronal cells after treatment with 6-hydroxydopamine , 2003, Neuroscience Letters.

[223]  Anne-Marie Rouquette,et al.  Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. , 2003, American journal of clinical pathology.

[224]  Li-Rong Yu,et al.  Proteomic analysis by two-dimensional polyacrylamide gel electrophoresis. , 2003, Advances in protein chemistry.

[225]  Roger E Bumgarner,et al.  Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. , 2001, Science.

[226]  P. Cutler.  Protein arrays: The current state‐of‐the‐art , 2003, Proteomics.

[227]  W. Robinson,et al.  Protein and peptide array analysis of autoimmune disease. , 2002, BioTechniques.